Delivery Order SPE2DR25D2206-SPE2DR26F9AG4
Award Date 11/5/25
Potential Completion Date 11/28/25
Potential Value $61K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $37,864.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of YERVOY (ipilimumab) 200 mg/40 mL vials. The contract, awarded on May 12, 2025, with an ultimate completion date of June 3, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $36,457.87 to AmerisourceBergen Drug Corp for YERVOY (ipilimumab) 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract was awarded on August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $114,789.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of YERVOY 200 mg/40 mL vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 28, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of YERVOY (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $22,870.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set to be completed by September 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $102,842.87 to AmerisourceBergen Drug Corp for the supply of Yervoy (ipilimumab) 200 mg/40 mL vials. This competitively awarded, firm fixed-price delivery order is set to be completed by October 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,435.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for YERVOY 50 mg/10 mL vials on October 17, 2025, with completion targeted for November 7, 2025. This non-set-aside award represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $22,957.99 to AmerisourceBergen Drug Corp for the supply of Yervoy 200 mg/40 ml vials on October 31, 2025, with an ultimate completion date of November 24, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $18,076.83 to AmerisourceBergen Drug Corp for the supply of Yervoy 50 mg/10 mL vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, utilizes firm fixed-price pricing under a non-competitive set-aside contract. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $57,351.44 for YERVOY 200 mg/40 mL vials from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability to meet federal procurement standards. The order is expected to be completed by...
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...